Jude Onyia, Chief Scientific Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 4,662 shares at $113.57 ($529K) on 2023-11-29, disclosed to the SEC on 2023-12-01.
Scheduled sale ($529k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $113.57 | 2,331 | $265K | 50.0% |
| 2 | $113.57 | 2,331 | $265K | 50.0% |
| Total | $113.57 avg | 4,662 | $529K | 100% |
| Filing → |
| NBIX | SELL | 2025-07-11 | $15.6M | — | Filing → |
| NBIX | SELL | 2025-07-07 | $5.3M | — | Filing → |
| NBIX | SELL | 2025-02-14 | $672K | — | Filing → |